GSA Capital Partners’s NeoGenomics NEO Stock Holding History

GSA Capital Partners’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$404K	Buy	+54,385	New	+$572K	0.03%	1053
2025 Q3	–	Sell	-47,956	Closed	-$351K	–	1944
2025 Q2	$351K	Buy	+47,956	New	+$387K	0.02%	1161
2024 Q1	–	Sell	-11,479	Closed	-$186K	–	1850
2023 Q4	$186K	Buy	+11,479	New	+$188K	0.02%	1337
2023 Q2	–	Sell	-20,949	Closed	-$365K	–	1794
2023 Q1	$365K	Buy	+20,949	New	+$298K	0.04%	907
2021 Q2	–	Sell	-5,263	Closed	-$254K	–	1509
2021 Q1	$254K	Buy	+5,263	New	+$274K	0.04%	752
2019 Q1	–	Sell	-55,245	Closed	-$697K	–	1601
2018 Q4	$697K	Buy	+55,245	New	+$823K	0.08%	383
2017 Q4	–	Sell	-33,191	Closed	-$369K	–	1728
2017 Q3	$369K	Buy	+33,191	New	+$323K	0.03%	1139
2015 Q1	–	Sell	-137,424	Closed	-$573K	–	2171
2014 Q4	$573K	Buy	137,424 +25,722	+23%	+$118K	0.04%	841
2014 Q3	$582K	Buy	111,702 +93,300	+507%	+$479K	0.03%	832
2014 Q2	$61K	Buy	+18,402	New	+$61.2K	﹤0.01%	1744
2013 Q3	–	Sell	-37,450	Closed	-$149K	–	1623
2013 Q2	$149K	Buy	+37,450	New	+$143K	0.02%	1163

Other funds holding NEO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

GSA Capital Partners's NEO Position: Q1 2026 in Review

GSA Capital Partners opened a new position in NeoGenomics (NEO) in Q1 2026: 54,385 shares worth $404K. The stake represents 0.03% of the portfolio and ranks #1053 among its holdings. This is a return to the name: GSA Capital Partners previously reported a position in NEO as recently as Q2 2025.

GSA Capital Partners first reported a position in NEO in Q2 2013 and has held it in 11 quarters since. The position peaked at $697K in Q4 2018. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

GSA Capital Partners held 54,385 shares of NeoGenomics worth $404K as of Q1 2026.
NeoGenomics was a new GSA Capital Partners position in Q1 2026.
NeoGenomics made up 0.03% of GSA Capital Partners's portfolio in Q1 2026, its #1053 holding.
GSA Capital Partners first reported a position in NeoGenomics in Q2 2013 and has held it in 11 quarters since.
GSA Capital Partners's NeoGenomics position peaked at $697K in Q4 2018.
253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.